IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 130 filers reported holding IMMUNITYBIO INC in Q3 2022. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9,971,866 | +915.1% | 1,577,827 | +762.5% | 0.00% | – |
| Q1 2024 | $982,334 | +7.0% | 182,930 | 0.0% | 0.00% | – |
| Q4 2023 | $918,310 | +197.0% | 182,930 | 0.0% | 0.00% | – |
| Q3 2023 | $309,152 | -7.1% | 182,930 | 0.0% | 0.00% | – |
| Q2 2023 | $332,932 | 0.0% | 182,930 | 0.0% | 0.00% | – |
| Q1 2023 | $332,932 | -55.4% | 182,930 | +24.3% | 0.00% | – |
| Q4 2022 | $746,294 | -99.9% | 147,198 | +8.7% | 0.00% | – |
| Q3 2022 | $672,715,000 | +17.4% | 135,355 | -12.1% | 0.00% | – |
| Q2 2022 | $573,018,000 | +1.3% | 154,037 | +52.7% | 0.00% | – |
| Q1 2022 | $565,832,000 | -7.7% | 100,861 | 0.0% | 0.00% | – |
| Q4 2021 | $613,236,000 | +45.9% | 100,861 | +133.8% | 0.00% | – |
| Q3 2021 | $420,174,000 | +13.5% | 43,139 | +66.4% | 0.00% | – |
| Q2 2021 | $370,166,000 | -28.1% | 25,922 | +19.5% | 0.00% | – |
| Q1 2021 | $515,158,000 | – | 21,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 335,709 | $2,121,681 | 1.13% |
| Accurate Wealth Management, LLC | 560,000 | $3,561,600 | 0.85% |
| ALLEN HOLDING INC /NY | 687,571 | $4,345,449 | 0.54% |
| SHEETS SMITH WEALTH MANAGEMENT | 665,995 | $4,209,088 | 0.50% |
| Cormorant Asset Management, LP | 1,250,000 | $7,900,000 | 0.46% |
| Clearwater Capital Advisors, LLC | 482,549 | $3,049,710 | 0.32% |
| WEALTH EFFECTS LLC | 87,500 | $553,000 | 0.20% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $609,457 | 0.19% |
| Virtus ETF Advisers LLC | 56,107 | $354,596 | 0.17% |
| COLLECTIVE FAMILY OFFICE LLC | 70,355 | $444,644 | 0.13% |